These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36094610)

  • 21. Whole genome joint analysis reveals ATM:C.1564_1565del variant segregating with Ataxia-Telangiectasia and breast cancer.
    Ćuk M; Unal B; Hayes CP; Walker M; Bevanda A; Antolović V; Ghazani AA
    Cancer Genet; 2024 Aug; 286-287():43-47. PubMed ID: 39067332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The spectrum of ATM missense variants and their contribution to contralateral breast cancer.
    Broeks A; Braaf LM; Huseinovic A; Schmidt MK; Russell NS; van Leeuwen FE; Hogervorst FB; Van 't Veer LJ
    Breast Cancer Res Treat; 2008 Jan; 107(2):243-8. PubMed ID: 17393301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Loss-of-Function Mutations Within the FANCM Gene and Early-Onset Familial Breast Cancer.
    Neidhardt G; Hauke J; Ramser J; Groß E; Gehrig A; Müller CR; Kahlert AK; Hackmann K; Honisch E; Niederacher D; Heilmann-Heimbach S; Franke A; Lieb W; Thiele H; Altmüller J; Nürnberg P; Klaschik K; Ernst C; Ditsch N; Jessen F; Ramirez A; Wappenschmidt B; Engel C; Rhiem K; Meindl A; Schmutzler RK; Hahnen E
    JAMA Oncol; 2017 Sep; 3(9):1245-1248. PubMed ID: 28033443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy.
    Pitter KL; Casey DL; Lu YC; Hannum M; Zhang Z; Song X; Pecorari I; McMillan B; Ma J; Samstein RM; Pei IX; Khan AJ; Braunstein LZ; Morris LGT; Barker CA; Rimner A; Alektiar KM; Romesser PB; Crane CH; Yahalom J; Zelefsky MJ; Scher HI; Bernstein JL; Mandelker DL; Weigelt B; Reis-Filho JS; Lee NY; Powell SN; Chan TA; Riaz N; Setton J
    J Natl Cancer Inst; 2021 Mar; 113(3):266-273. PubMed ID: 32726432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of germline missense mutations and rare allelic variants in the ATM gene in early-onset breast cancer.
    Izatt L; Greenman J; Hodgson S; Ellis D; Watts S; Scott G; Jacobs C; Liebmann R; Zvelebil MJ; Mathew C; Solomon E
    Genes Chromosomes Cancer; 1999 Dec; 26(4):286-94. PubMed ID: 10534763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of a Pathogenic Variant rs139379666 (p. P2974L) in
    Guo X; Lin W; Bai M; Li H; Wen W; Zeng C; Chen Z; He J; Chen J; Cai Q; Long J; Jia WH; Shu XO; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1308-1315. PubMed ID: 31160347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline.
    van Os NJ; Roeleveld N; Weemaes CM; Jongmans MC; Janssens GO; Taylor AM; Hoogerbrugge N; Willemsen MA
    Clin Genet; 2016 Aug; 90(2):105-17. PubMed ID: 26662178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between twenty missense ATM variants and breast cancer risk: the Multiethnic Cohort.
    Bretsky P; Haiman CA; Gilad S; Yahalom J; Grossman A; Paglin S; Van Den Berg D; Kolonel LN; Skaliter R; Henderson BE
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):733-8. PubMed ID: 12917204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer.
    Stredrick DL; Garcia-Closas M; Pineda MA; Bhatti P; Alexander BH; Doody MM; Lissowska J; Peplonska B; Brinton LA; Chanock SJ; Struewing JP; Sigurdson AJ
    Hum Mutat; 2006 Jun; 27(6):538-44. PubMed ID: 16652348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline variants of Brazilian women with breast cancer and detection of a novel pathogenic ATM deletion in early-onset breast cancer.
    Bandeira G; Rocha K; Lazar M; Ezquina S; Yamamoto G; Varela M; Takahashi V; Aguena M; Gollop T; Zatz M; Passos-Bueno MR; Krepischi A; Okamoto OK
    Breast Cancer; 2021 Mar; 28(2):346-354. PubMed ID: 32986223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.
    Scott SP; Bendix R; Chen P; Clark R; Dork T; Lavin MF
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):925-30. PubMed ID: 11805335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.
    Tavtigian SV; Oefner PJ; Babikyan D; Hartmann A; Healey S; Le Calvez-Kelm F; Lesueur F; Byrnes GB; Chuang SC; Forey N; Feuchtinger C; Gioia L; Hall J; Hashibe M; Herte B; McKay-Chopin S; Thomas A; Vallée MP; Voegele C; Webb PM; Whiteman DC; ; ; ; Sangrajrang S; Hopper JL; Southey MC; Andrulis IL; John EM; Chenevix-Trench G
    Am J Hum Genet; 2009 Oct; 85(4):427-46. PubMed ID: 19781682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk.
    West AH; Blazer KR; Stoll J; Jones M; Weipert CM; Nielsen SM; Kupfer SS; Weitzel JN; Olopade OI
    Fam Cancer; 2018 Oct; 17(4):495-505. PubMed ID: 29445900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry.
    Bernstein JL; Teraoka S; Southey MC; Jenkins MA; Andrulis IL; Knight JA; John EM; Lapinski R; Wolitzer AL; Whittemore AS; West D; Seminara D; Olson ER; Spurdle AB; Chenevix-Trench G; Giles GG; Hopper JL; Concannon P
    Hum Mutat; 2006 Nov; 27(11):1122-8. PubMed ID: 16958054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare germline ATM variants of uncertain significance in chronic lymphocytic leukaemia and other cancers.
    Petrackova A; Savara J; Turcsanyi P; Gajdos P; Papajik T; Kriegova E
    Br J Haematol; 2022 Nov; 199(3):371-381. PubMed ID: 36029002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast and colorectal cancer risks among over 6,000 CHEK2 pathogenic variant carriers: A comparison of missense versus truncating variants.
    Mundt E; Mabey B; Rainville I; Ricker C; Singh N; Gardiner A; Manley S; Slavin T
    Cancer Genet; 2023 Nov; 278-279():84-90. PubMed ID: 37839337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variants in ATM, H2AFX and MRE11 genes and susceptibility to breast cancer in the polish population.
    Podralska M; Ziółkowska-Suchanek I; Żurawek M; Dzikiewicz-Krawczyk A; Słomski R; Nowak J; Stembalska A; Pesz K; Mosor M
    BMC Cancer; 2018 Apr; 18(1):452. PubMed ID: 29678143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls.
    Fletcher O; Johnson N; dos Santos Silva I; Orr N; Ashworth A; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Burwinkel B; Bartram CR; Meindl A; Schmutzler RK; Cox A; Brock I; Elliott G; Reed MW; Southey MC; Smith L; Spurdle AB; Hopper JL; Couch FJ; Olson JE; Wang X; Fredericksen Z; Schürmann P; Waltes R; Bremer M; Dörk T; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Humphreys K; Liu J; Ahmed S; Dunning AM; Maranian M; Pharoah PD; Chenevix-Trench G; ; ; Beesley J; Bogdanova NV; Antonenkova NN; Zalutsky IV; Anton-Culver H; Ziogas A; Brauch H; Ko YD; Hamann U; ; Fasching PA; Strick R; Ekici AB; Beckmann MW; Giles GG; Severi G; Baglietto L; English DR; Milne RL; Benítez J; Arias JI; Pita G; Nordestgaard BG; Bojesen SE; Flyger H; Kang D; Yoo KY; Noh DY; Mannermaa A; Kataja V; Kosma VM; García-Closas M; Chanock S; Lissowska J; Brinton LA; Chang-Claude J; Wang-Gohrke S; Broeks A; Schmidt MK; van Leeuwen FE; Van't Veer LJ; Margolin S; Lindblom A; Humphreys MK; Morrison J; Platte R; Easton DF; Peto J;
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2143-51. PubMed ID: 20826828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uncovering variable neoplasms between ATM protein-truncating and common missense variants using 394 694 UK Biobank exomes.
    Jiang X; O'Neill A; Smith KR; Lai Z; Carss K; Wang Q; Petrovski S
    Genes Chromosomes Cancer; 2022 Sep; 61(9):523-529. PubMed ID: 35394676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers.
    Cragun D; Weidner A; Tezak A; Clouse K; Pal T
    Breast Cancer Res Treat; 2020 Jul; 182(2):421-428. PubMed ID: 32445176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.